Package 33342-238-07

{"route": ["ORAL"], "spl_id": "de3914b8-5c5c-4b11-a9f9-39f592d51c1d", "openfda": {"nui": ["N0000175463", "N0000175460", "N0000009948", "N0000190118", "N0000187064"], "upc": ["0333342238078", "0333342238122"], "unii": ["99DK7FVK1H"], "rxcui": ["1095712"], "spl_set_id": ["2620b114-f53f-44f1-8708-697e86343090"], "pharm_class_epc": ["Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-238-07)", "package_ndc": "33342-238-07", "marketing_start_date": "20171007"}], "brand_name": "NEVIRAPINE", "product_id": "33342-238_de3914b8-5c5c-4b11-a9f9-39f592d51c1d", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Non-Nucleoside Analog [EXT]", "Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "33342-238", "generic_name": "NEVIRAPINE", "labeler_name": "Macleods Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "NEVIRAPINE", "active_ingredients": [{"name": "NEVIRAPINE", "strength": "400 mg/1"}], "application_number": "ANDA206879", "marketing_category": "ANDA", "marketing_start_date": "20171007", "listing_expiration_date": "20261231"}